Imaging in the cardiovascular and metabolic disease area

► We introduce the use of imaging in cardiovascular and metabolic drug development. ► We draw attention to subtleties in its application and advances in the field. ► Efficacy biomarkers for obesity, diabetes and atherosclerosis are discussed.